Concussion Care Starts in the ED Webinar

Thursdsay, February 23 at 1 PM Eastern

Indications for Use
For Patients
Portal

About
Emergency
Department
Science &
Technology
Concussion
Military
Publications,
Media & Blog
Indications for Use
For Patients
Portal

Get a demo

Assess mild head injured patients in minutes

BrainScope is the only FDA cleared non-invasive medical device that objectively assesses head injured patients for both brain bleeds & concussions at point of care.

Demonstrated potential to reduce head CT in the ED by 30%-60% image-png-Feb-09-2021-03-09-15-53-AM

8 FDA clearances
12 years of R&D
33 peer reviewed publications
14,000+ subject evaluations

“Utilizing BrainScope gives me more actionable clinical data to assess concussion than is available to emergency physicians in the ED today."

Marsh Cuttino, MD FAAEM FACEP, Emergency Physician, Richmond VA

"When BrainScope is used independently or in conjunction with a standard head rule, fewer patients are scanned—resulting in less radiation exposure, less time in the ED, improved patient experience."

David Levine, MD, FACEP, Emergency Physician, Brunswick OH

“BrainScope gives our patients peace of mind—with BrainScope, we have saved 43% of patients from unnecessary radiation due to CT scans. ”

Mark Christensen, MD, Regional Director, Alteon Emergency Medicine - North Alabama

Reduction in unnecessary CT scans for head injury in the emergency department using an FDA cleared device

Naunheim R, Konstantinovic Koscso M, Poirier R. Reduction in unnecessary CT scans for head injury in the emergency department using an FDA cleared device. American Journal of Emergency Medicine. 2019 Oct;37(10):1987-1988. doi: 10.1016/j.ajem.2019.04.037

Article Info

Emergency Department (ED) visits for mild Traumatic Head Injury (mTBI) have greatly increased due to more awareness of potential consequences of such injuries. While the vast majority (>80%) of mTBI patients who go to the ED receive a head CT scan, >90% of them are found to be negative. This practice unnecessarily exposes these patients to radiation, increases the use of ED resources, and lengthens throughput times. The integration of reliable, objective predictors of intracranial injury for making important initial assessment decisions can impact significantly on this practice.

Clinical Utility of EEG Based Biomarker for the Triage of Head Injured Patients in the ED: INOVA Pilot Study

Clay, M. Clinical Utility of an EEG Based Biomarker for the Triage of Head Injured Patients in the ED: INOVA Pilot Study. White Paper, 2021.

White Paper Info

Within one rapid EEG test at the point of care, BrainScope provides objective data on both brain bleeds and concussions to assist healthcare providers in evaluating head injured patients. This study was successful in determining utilization, staff assessment, and patient experience of the BrainScope technology in daily use. The results of the trial were overwhelmingly positive.

Designed for accurate, fast & easy assessment of mild head injuries

Accurate

Demonstrated 99% accuracy in identifying the likelihood of the smallest detectable level of blood (>1 mL).

Determine concussion status at same time with same setup and recording.

Fast

Demonstrated to reduce patient length of stay in the emergency department.

Prep, test, result in under 20 minutes.

Easy

Integrate easily into busy environments.

Intuitive design requires minimal to no training to operate.

Mild traumatic brain injury

A patient with mild traumatic brain injury is a person who has had a traumatically induced physiological disruption of brain function, as manifested by at least one of the following:

1. Any period of loss of consciousness;

2. Any loss of memory for events immediately before or after the accident;

3. Any alteration in mental state at the time of the accident (e.g., feeling dazed, disoriented, or confused); and

4. Focal neurological deficit(s) that may or may not be transient; but where the severity of the injury does not exceed the following: loss of consciousness of approximately 30 minutes or less; after 30 minutes, an initial Glasgow Coma Scale (GCS) of 13–15; and post traumatic amnesia (PTA) not greater than 24 hours.

This definition includes:

1. The head being struck,

2. The head striking an object, and

3. The brain undergoing an acceleration/deceleration movement (i.e., whiplash) without direct external trauma to the head.

Ref : www.acrm.org

Curious to see how it works?

Clinical performance you can trust

FDA cleared AI/machine learning derived advanced pattern recognition algorithms are used to determine the likelihood of structural and functional brain injury with high independently validated accuracy.

Learn More

Add confidence to diagnose at point of care using BrainScope

Highly validated clinical performance

Emergency Department Triage of Traumatic Head Injury Using Brain Electrical Activity Biomarkers: A Multisite Prospective Observational Validation Trial

Hanley D, Prichep LS, Bazarian J, Huff JS, Naunheim R, Garrett J, Jones E, Wright DW, O'Neill J, Badjatia N, Gandhi D, Curley K, Chiacchierini R, O'Neil B, Hack D. Emergency Department Triage of Traumatic Head Injury Using Brain Electrical Activity Biomarkers: A Multisite Prospective Observational Validation Trial. Academic Emergency Medicine. 2017; 24(5):617-627.

A Brain Electrical Activity (EEG) Based Biomarker of Functional Impairment in Traumatic Head Injury: A Multisite Validation Trial

Hanley D, Prichep LS, Badjatia N, Bazarian J, Chiacchierini R, Curley K, Garrett J, Jones E, Naunheim R, O'Neil B, O'Neill J, Wright DW, Huff JS. A Brain Electrical Activity (EEG) Based Biomarker of Functional Impairment in Traumatic Head Injury: A Multisite Validation Trial. Journal of Neurotrauma. 2018; 35(1):41-47.

Validation of a Machine Learning Brain Electrical Activity-Based Index to Aid in Diagnosing Concussion Among Athletes

Bazarian J, Elbin R, Casa D, Hotz G, Neville C, Lopez R, Schnyer D, Yeargin S, Covassin T. Validation of a Machine Learning Brain Electrical Activity-Based Index to Aid in Diagnosing Concussion Among Athletes. JAMA Network Open. 2021;4(2) e2037349.